The company
ADMA Biologics Inc
ADMA · Nasdaq
ADMA stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 12.3% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $937K
- Insider sales, 12 months
- $2.7M
- Officials’ trades on record
- 8
- Institutions holding
- 297 (-30)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
8 disclosed lines: House 0, Senate 0, executive 8; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 22 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Jerrold B. GrossmanDirector | bought | 6,400at $7.91 | 27 May 2026filed 28 May 2026 |
| Jerrold B. GrossmanDirector | bought | 12,500at $8.01 | 12 May 2026filed 14 May 2026 |
| Jerrold B. GrossmanDirector | bought | 12,500at $8.01 | 11 May 2026filed 12 May 2026 |
| Adam S. GrossmanPresident and CEO | sold | 15,000at $15.16 | 16 Mar 2026filed 17 Mar 2026 |
| Adam S. GrossmanPresident and CEO | sold | 6,000at $15.16 | 16 Mar 2026filed 17 Mar 2026 |
| Kaitlin M. Kestenberg-MessinaCOO and SVP, Compliance | sold | 10,096at $15.63 | 9 Mar 2026filed 10 Mar 2026 |
| Steve ElmsDirector | bought | 7,000at $15.39 | 6 Mar 2026filed 9 Mar 2026 |
| Steve ElmsDirector | bought | 7,000at $15.67 | 5 Mar 2026filed 9 Mar 2026 |
| Adam S. GrossmanPresident and CEO | sold | 15,000at $16.08 | 17 Feb 2026filed 17 Feb 2026 |
| Adam S. GrossmanPresident and CEO | sold | 6,000at $16.08 | 17 Feb 2026filed 17 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 38,355,684$321.0M | +1,524,910+4.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 17,116,022$143.3M | +3,031,817+21.5% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 10,103,809$84.6M | -203,062−2.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 10,088,490$84.4M | +1,219,833+13.8% |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 9,339,414$78.2M | +7,530,006+416.2% |
| Capital Research Global Investorsreduced · filed 12 Aug 2026 | 8,756,374$73.3M | -2,434,742−21.8% |
| FIRST TRUST ADVISORS LPadded · filed 11 Aug 2026 | 7,798,351$65.3M | +7,438,134+2064.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 6,059,984$50.7M | +235,868+4.0% |
| Caligan Partners LPadded · filed 14 Aug 2026 | 5,725,007$47.9M | +968,496+20.4% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 5,274,597$44.1M | +4,713,770+840.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.